Skip to main content

Update on the Company’s management plans, and M&A Cooperation Framework Agreement signed between the Company’s subsidiary, Liaoning Kangbaier Biotechnology Development Co., Ltd. and the Anshan Tanbao Technology Co., Ltd.

Written by Customer Service on . Posted in Public Companies.

Panjin City, Liaoning Province, April 20, 2023 (GLOBE NEWSWIRE) — Kangbaier Biotechnology Development Co., Ltd. (“Kangbaier”), a wholly-owned subsidiary of Bitmis Corp. (“the Company”) (OTC: BIMT), has made a series of development plans including asset expansion, industrial upgrading, brand strengthening, channel expansion, and chain business under the management’s planning:

I. In the Panjin Food Industry Circular Economy Demonstration Park, we will build the “Kangbaier International Health Industrial Park”, which integrates R&D, production, logistics, office work and health care. We are implementing the relevant procedures and strive to put into construction in June 2023, and complete the first phase of construction before the end of the year.

II. Adhering to the strategic positioning as a product service providers for integrated transformation of agricultural high-tech achievements, we will steadily improve product development advantages, product quality advantages, cultural innovation advantages, and greatly improve the brand exposure and popularity of Kangbaier through Q&A, post bar, library, micro-blog, self-media, news sources, videos and other channels.

III. On the basis of Baijiakang Healthy Lifestyle Supermarket, we will expand various forms of chain business through direct marketing, alliance, mixed operation and other means to construct multi-type industrial layout, and further realize multi-terminal coverage on the supply chain commodities of Kangbaier from point to area.

IV. From the northeast to the whole country, we will unite the high-quality enterprises in the field of large agriculture and health through industrial merger and acquisition, and use capital to empower the rapid development of enterprises. 

On March 18, 2023, the M&A Cooperation Framework Agreement was signed between the Liaoning Kangbaier Biotechnology Development Co., Ltd. and the Anshan Tanbao Technology Co., Ltd. (“Tanbao Technology”). Founded in 2009, Tanbao Technology is an enterprise specializing in the development of healthy and environmental protection series products with agricultural straw as the main raw material. Kangbaier has cooperated with Tanbao Technology for many years. And they are interconnected and mutually empowered in terms of sales channels of the series products between carotene and negative oxygen ions. The M&A Cooperation Framework Agreement makes their cooperation to a new level and also marks the official opening of the strategic policy for integrating the upstream and downstream industrial chains through M&A and helping the rapid development of the enterprise. The M&A of high-quality enterprises not only meet its development needs for the capital market of Kangbaier, but also promote its construction for a converged supply chain to form a multi-form industrial layout, which is of great significance to the high-quality development of Kangbaier. The Company is currently conducting preliminary due diligence and other related works on Tanbao Technology.

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.